We are live on
!
Find out more
FNBOO
First National Bank of Omaha Portfolio holdings
AUM
$3.55B
1-Year Est. Return
27.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.97%
1 Year Est. Return
+27.24%
3 Year Est. Return
+70.89%
5 Year Est. Return
+96.41%
10 Year Est. Return
+340.36%
AUM
$1.65B
AUM Growth
+$31.8M
(+2%)
Cap. Flow
-$37.7M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
21.27%
Holding
342
New
12
Increased
71
Reduced
207
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robert Half
RHI
|
+$6.02M |
| 2 |
Abbott
ABT
|
+$5.92M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$5.72M |
| 4 |
Cintas
CTAS
|
+$1.59M |
| 5 |
InMode
INMD
|
+$1.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$6.11M |
| 2 |
LHCG
LHC Group LLC
LHCG
|
+$4.93M |
| 3 |
Labcorp
LH
|
+$3.78M |
| 4 |
Apple
AAPL
|
+$2.45M |
| 5 |
Microsoft
MSFT
|
+$2.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.97% |
| 2 | Financials | 13.16% |
| 3 | Healthcare | 11.99% |
| 4 | Industrials | 9.78% |
| 5 | Consumer Staples | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
Jazz Pharmaceuticals
JAZZ
$16.2B
| $5.66M | 0.34% |
+38,689
| New | +$5.72M |
|
102
American Tower
AMT
$79.4B
| $5.58M | 0.34% |
27,300
-1,066
| -4% | -$224K |
|
103
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $5.41M | 0.33% |
108,215
-7,195
| -6% | -$367K |
|
104
Tractor Supply
TSCO
$19B
| $5.39M | 0.33% |
114,570
+1,320
| +1% | +$60.1K |
|
105
Corpay
CPAY
$26.9B
| $5.18M | 0.31% |
24,548
-995
| -4% | -$202K |
|
106
Phillips 66
PSX
$90B
| $5.16M | 0.31% |
50,910
+13,089
| +35% | +$1.33M |
|
|
HZNP
107
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.09M | 0.31% |
46,651
-55,282
| -54% | -$6.11M |
|
108
MasTec
MTZ
$22.6B
| $4.98M | 0.3% |
52,768
-2,273
| -4% | -$216K |
|
109
Invesco QQQ Trust
QQQ
$481B
| $4.96M | 0.3% |
15,451
+19
| +0.1% | +$5.61K |
|
110
CDW
CDW
$17.1B
| $4.7M | 0.28% |
24,110
-1,069
| -4% | -$210K |
|
|
EA
111
DELISTED
Electronic Arts
EA
| $4.68M | 0.28% |
38,875
-878
| -2% | -$103K |
|
112
Wells Fargo
WFC
$269B
| $4.63M | 0.28% |
123,800
-1,702
| -1% | -$74.2K |
|
113
Global Payments
GPN
$23.4B
| $4.62M | 0.28% |
43,892
-222
| -0.5% | -$24.1K |
|
114
Edwards Lifesciences
EW
$53.6B
| $4.61M | 0.28% |
55,725
-1,994
| -3% | -$157K |
|
115
Regeneron Pharmaceuticals
REGN
$82.2B
| $4.52M | 0.27% |
5,506
-254
| -4% | -$192K |
|
116
Lockheed Martin
LMT
$140B
| $4.4M | 0.27% |
9,304
-102
| -1% | -$47.8K |
|
117
Morgan Stanley
MS
$342B
| $4.4M | 0.27% |
50,068
-1,970
| -4% | -$184K |
|
118
Timken Company
TKR
$9.03B
| $4.37M | 0.27% |
53,513
-2,256
| -4% | -$183K |
|
119
Becton Dickinson
BDX
$50B
| $4.28M | 0.26% |
17,299
-424
| -2% | -$104K |
|
120
Honeywell
HON
$74.6B
| $4.28M | 0.26% |
23,772
+31
| +0.1% | +$5.83K |
|
121
Dorman Products
DORM
$3.97B
| $4.27M | 0.26% |
49,466
-541
| -1% | -$48.2K |
|
122
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
| $4.23M | 0.26% |
20,740
-122
| -0.6% | -$24.4K |
|
123
American Water Works
AWK
$26.8B
| $4.18M | 0.25% |
28,562
-625
| -2% | -$92.6K |
|
124
Moody's
MCO
$82.8B
| $4.14M | 0.25% |
13,530
-367
| -3% | -$111K |
|
125
Duke Energy
DUK
$96.3B
| $4.1M | 0.25% |
42,544
-72
| -0.2% | -$7.11K |
|
Similar funds
TYCC
WWA
VPC
BPS
BCP
TCM
SL
ACM
First National Bank of Omaha's Q1 2023 Portfolio in Review
As of Q1 2023, First National Bank of Omaha held 342 positions worth $1.65B, up 2% from $1.62B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
First National Bank of Omaha's Q1 2023 filing shows 12 new, 71 increased, 207 reduced and 12 closed positions. Its largest new stake was Jazz Pharmaceuticals: 38,689 shares worth $5.66M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $6.11M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- First National Bank of Omaha's largest Q1 2023 buy was Jazz Pharmaceuticals: 38,689 shares worth $5.66M.
- First National Bank of Omaha added most to Robert Half in Q1 2023, an estimated $6.02M increase.
- First National Bank of Omaha's biggest Q1 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $6.11M.
- First National Bank of Omaha fully exited LHC Group LLC in Q1 2023, selling an estimated $4.93M.
- First National Bank of Omaha's ten largest holdings make up 21% of its $1.65B portfolio in Q1 2023.
- First National Bank of Omaha opened 12 new positions and closed 12 in Q1 2023.
- First National Bank of Omaha's portfolio value rose 2% quarter-over-quarter to $1.65B.
Based on First National Bank of Omaha's 13F filing for Q1 2023, filed 3 May 2023.